3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer
Clinical trial NCT00095888 · TERMINATED
Trial details
- NCT number
- NCT00095888
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2006-06-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.